180 Life Sciences Corp. Files 8-K with Agreement Termination, Director Changes
Ticker: FRMM · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1690080
| Field | Detail |
|---|---|
| Company | 180 Life Sciences CORP. (FRMM) |
| Form Type | 8-K |
| Filed Date | Jun 18, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: agreement-termination, management-change, corporate-governance
Related Tickers: ATNF
TL;DR
180 Life Sciences terminated a deal and shuffled execs/directors. Big changes ahead?
AI Summary
On June 12, 2025, 180 Life Sciences Corp. reported on several key events including the termination of a material definitive agreement and changes in its board of directors and officer compensation. The company also filed financial statements and exhibits related to these events.
Why It Matters
This filing indicates significant corporate restructuring and potential shifts in strategic direction for 180 Life Sciences Corp., which could impact its future operations and investor outlook.
Risk Assessment
Risk Level: medium — The termination of a material definitive agreement and changes in leadership can signal underlying business challenges or strategic pivots, introducing uncertainty.
Key Players & Entities
- 180 Life Sciences Corp. (company) — Registrant
- June 12, 2025 (date) — Earliest event reported
- KBL Merger Corp. IV (company) — Former company name
FAQ
What was the material definitive agreement that was terminated?
The filing indicates the termination of a material definitive agreement, but the specific details of this agreement are not provided in the excerpt.
What specific changes occurred regarding directors or officers?
The filing notes the departure of directors or certain officers, the election of directors, and the appointment of certain officers, along with details on compensatory arrangements, but the specific individuals are not named in the excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on June 12, 2025.
What is the SIC code for 180 Life Sciences Corp.?
The Standard Industrial Classification (SIC) code for 180 Life Sciences Corp. is 2834, which corresponds to Pharmaceutical Preparations.
What was the former name of 180 Life Sciences Corp.?
The former name of 180 Life Sciences Corp. was KBL Merger Corp. IV, with a date of name change on November 15, 2016.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding 180 Life Sciences Corp. (FRMM).